From: Patients, payers and developers of Orphan Medicinal Products: lessons learned from 10 years’ multi-stakeholder dialogue on improving access in Europe via MoCA
ATC code
Number of OMPs
A(limentary)
5
B(lood)
4
C(ardiovascular)
3
(Onco)L(ogy)
2
M(usculoskeletal)
N(ervous system)
R(espiratory)
S(ensory)
1